Back to search

Influence of functional polymorphisms of the gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia

Data up to Jan 2025

Published2004
Citations88
References45

Total Citations Per Year

Abstract

References (45)

Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

2000 • 2,358 citations

BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER

1999 • 2,049 citations

Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects

2003 • 1,750 citations

Expression of a multidrug-resistance gene in human tumors and tissues.

1987 • 1,547 citations

Identification of functionally variant MDR1 alleles among European Americans and African Americans

2001 • 1,000 citations

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

2004 • 900 citations

Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.

1994 • 777 citations

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects

2001 • 757 citations

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.

1994 • 685 citations

Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

1999 • 663 citations

Mechanism of inhibition of cell proliferation by Vinca alkaloids.

1991 • 534 citations

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

2001 • 418 citations

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.

2001 • 319 citations

Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene

2002 • 307 citations

Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients

2003 • 281 citations

Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies

2002 • 269 citations

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein

2002 • 268 citations

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

2003 • 248 citations

MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.

2002 • 247 citations

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

2003 • 226 citations

A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

2002 • 204 citations

The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol

2002 • 201 citations

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

2002 • 194 citations

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

2003 • 169 citations

Pharmacological insights from P-glycoprotein knockout mice.

1998 • 147 citations

Polymorphisms in the ABC drug transporter gene MDR1

2001 • 136 citations

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

2003 • 133 citations

The pharmacokinetics of [3H]‐vincristine in man

1977 • 105 citations

Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.

2002 • 104 citations

Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro

1996 • 98 citations

Mdr1 Limits CYP3A Metabolism in Vivo

2000 • 90 citations

Cytochrome P450?inducing antiepileptics increase the clearance of vincristine in patients with brain tumors

1999 • 90 citations

Biliary excretion of vincristine

1978 • 83 citations

Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance.

2000 • 76 citations

Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia

2002 • 71 citations

Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.

1999 • 70 citations

Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver

1992 • 70 citations

Vincristine disposition in children with acute lymphoblastic leukemia

1995 • 60 citations

Neurotoxicity of antineoplastic agents

1993 • 45 citations

Hyponatremia and syndrome of inappropriate anti‐diuretic hormone reported with the use of Vincristine®: an over‐representation of Asians?

2002 • 43 citations

Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats

1995 • 40 citations

Homozygous Disruption of the mdr1a P-glycoprotein Gene Affects Blood-Nerve Barrier Function in Mice Administered with Neurotoxic Drugs

2001 • 35 citations

Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction

1991 • 35 citations

P-glycoprotein expression in capillary endothelial cells of the 7th and 8th nerves of guinea pig in relation to blood–nerve barrier sites

1997 • 24 citations

An Automated Method for the Bioanalysis of Vincristine Suitable for Therapeutic Drug Monitoring and Pharmacokinetic Studies in Young Children

2001 • 19 citations

Cited By (0)

Loading...
Influence of functional polymorphisms of the gene on vincristine pharmacokinetics in… (2004) – Clinical Pharmacology & Therapeutics | Metascience Observatory Explorer